stockportfolio.pro
Stocks / A vs BDX
A vs BDX
Agilent Technologies, Inc. and Becton, Dickinson and Company side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Agilent Technologies, Inc. (A) | Becton, Dickinson and Company (BDX) | |
|---|---|---|
| Market cap | $36.9B | $40.1B |
| Revenue (latest FY) | $6.95B | $21.84B |
| Net income (latest FY) | $1.30B | $1.68B |
| Revenue growth (5y CAGR) | 5.4% | 6.3% |
| Net margin | 18.8% | 7.7% |
| Return on equity | 19.3% | 6.6% |
| P/E ratio | 26.1 | 25.4 |
| Dividend yield | 0.8% | 2.9% |
| Profitable years (of last 10) | 10 | 10 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open A — free Open BDX — freeFrequently asked questions
Which is bigger, A or BDX?
Becton, Dickinson and Company is larger by market capitalization — $40.1B versus $36.9B.
Which grows faster, A or BDX?
Over the last five fiscal years, Becton, Dickinson and Company grew revenue faster — 6.3%/yr versus 5.4%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.